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Introduction: Acute kidney injury (AKI) is a common complication in intensive care unit (ICU) patients and is
associated with increased morbidity and mortality. We compared long-term outcome and quality of life (QOL) in
ICU patients with AKI treated with renal replacement therapy (RRT) with matched non-AKI-RRT patients.
Methods: Over 1 year, consecutive adult ICU patients were included in a prospective cohort study. AKI-RRT patients
alive at 1 year and 4 years were matched with non-AKI-RRT survivors from the same cohort in a 1:2 (1 year) and 1:1
(4 years) ratio based on gender, age, Acute Physiology and Chronic Health Evaluation II score, and admission
category. QOL was assessed by the EuroQoL-5D and the Short Form-36 survey before ICU admission and at
3 months, 1 and 4 years after ICU discharge.
Results: Of 1953 patients, 121 (6.2 %) had AKI-RRT. AKI-RRT hospital survivors (44.6 %; N = 54) had a 1-year and
4-year survival rate of 87.0 % (N = 47) and 64.8 % (N = 35), respectively. Forty-seven 1-year AKI-RRT patients were
matched with 94 1-year non-AKI-RRT patients. Of 35 4-year survivors, three refused further cooperation, three were
lost to follow-up, and one had no control. Finally, 28 4-year AKI-RRT patients were matched with 28 non-AKI-RRT
patients. During ICU stay, 1-year and 4-year AKI-RRT patients had more organ dysfunction compared to their
respective matches (Sequential Organ Failure Assessment scores 7 versus 5, P < 0.001, and 7 versus 4, P < 0.001).
Long-term QOL was, however, comparable between both groups but lower than in the general population. QOL
decreased at 3 months, improved after 1 and 4 years but remained under baseline level. One and 4 years after ICU
discharge, 19.1 % and 28.6 % of AKI-RRT survivors remained RRT-dependent, respectively, and 81.8 % and 71 % of
them were willing to undergo ICU admission again if needed.
Conclusion: In long-term critically ill AKI-RRT survivors, QOL was comparable to matched long-term critically ill
non-AKI-RRT survivors, but lower than in the general population. The majority of AKI-RRT patients wanted to be
readmitted to the ICU when needed, despite a higher severity of illness compared to matched non-AKI-RRT
patients, and despite the fact that one quarter had persistent dialysis dependency.Introduction
Acute kidney injury (AKI) treated with renal replacement
therapy (RRT) affects approximately 5–10 % of intensive
care unit (ICU) patients [1]. These patients are amongst
the most severely ill patients in the ICU, as illustrated by
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ing end-stage renal disease, and experience decreased
long-term survival [4–8]. Therefore, to fully appreciate
outcomes of critically ill AKI-RRT survivors, indices re-
garding long-term morbidity and quality of life (QOL)
should also be taken into account [9, 10].
Major reductions in long-term QOL in critically ill
patients are seen in severe acute respiratory distress
syndrome, prolonged mechanical ventilation, severe sep-
sis, and after major trauma, all conditions frequently
associated with AKI-RRT [11]. Data regarding QOL inle is distributed under the terms of the Creative Commons Attribution
mons.org/licenses/by/4.0), which permits unrestricted use, distribution,
you give appropriate credit to the original author(s) and the source,
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decreased QOL compared to the general population but
perceive QOL as good [12, 13]. However, these studies
were either retrospective [14–17], evaluated QOL after a
short term [12–15, 17–21], lacked baseline QOL assess-
ment [12–15, 18, 22], or dated back more than a decade
[14–16, 18, 23]. It is also unclear whether impairment in
long-term QOL is the consequences of critical illness,
AKI-RRT, pre-existing co-morbidities, or a combination
of these.
The aim of the present study was to assess long-term
outcomes and QOL of critically ill AKI-RRT patients at
baseline, and at 3 months, 1 year and 4 years after ICU
discharge and to compare QOL with a cohort of
matched non-AKI-RRT patients [24].
Methods
Design, patients, and setting
The cohort described in this study is a subgroup of a
prospective observational cohort. During one year
(March 2008 to March 2009), all consecutively admitted
adult patients at the 14-bed medical ICU (MICU), the
22-bed surgical ICU (SICU), and the 6-bed burns unit of
the Ghent University Hospital, Belgium, were screened
to study QOL and cost-effectiveness of intensive care
[25]. Exclusion criteria were age <16 years and admis-
sion to the ICU after cardiac surgery. In case of multiple
ICU admissions, only the first was considered.
In this study, only AKI-RRT patients of the larger
cohort were included. Chronic hemodialysis patients
were excluded. The attending critical care physician and
consulting nephrologist assessed indication for RRT and
modality.
To study the impact of RRT on long-term outcome and
QOL, we performed a matched cohort study, according to
the STROBE guidelines [26]. Included AKI-RRT patients
alive at 1 year after hospital discharge were defined as
exposed patients and individually matched with 1-year
non-AKI-RRT survivors (defined as nonexposed patients)
from the same cohort. Being a patient in the non-AKI-
RRT group did not imply normal kidney function: it
implied no treatment with RRT. To correct for possible
bias, we excluded patients who needed RRT but who did
not receive RRT due to therapeutic restrictions. Equally,
AKI-RRT patients alive at time of this study (average
4 years later) were individually matched with 4-year non-
AKI-RRT survivors. The exposed to nonexposed ratio was
aimed at 1:2 to reduce risk of selection bias. When there
were more than two nonexposed patients for an exposed
patient, only the nonexposed patient with the best overall
match was selected. If an exposed patient could only be
properly matched to one nonexposed patient, we accepted
matching in a 1:1 ratio for the respective cohort in order
to avoid an imbalance of characteristics and to retain thebest possible matching. Matching was based on gender,
age (±5 years), Acute Physiology and Chronic Health
Evaluation (APACHE) II score (±5), and admission
category.
Data collection and definitions
Variables collected within the first 24 hours of ICU ad-
mission included age, gender, body mass index, personal,
proxy, and family practitioner contact data, living situ-
ation, activity of daily living, co-morbidity as measured
by the Charlson co-morbidity index [27], hospitalization
in the last 6 months, main reason for ICU admission,
APACHE II score [28], Sequential Organ Failure Assess-
ment (SOFA) score [29], need for mechanical ventila-
tion, use of any vasopressors, and need for RRT. During
ICU stay, SOFA scores, need for mechanical ventilation,
vasopressors, RRT, and do-not-resuscitate codes were
collected on a daily base. ICU length of stay (LOS), hos-
pital LOS, and vital status at ICU and hospital discharge,
and at 3 months, 1 year and 4 years following ICU dis-
charge, were collected for each patient.
Values of serum creatinine for AKI-RRT patients were
extracted from the STARRT database, which includes
all relevant renal and RRT data of ICU patients with
AKI-RRT treated in our hospital, and from laboratory
data in control patients. The estimated glomerular filtra-
tion rate (eGFR) was calculated using the Chronic Kidney
Disease Epidemiology Collaboration formula [30]. Renal
recovery was defined as independence from RRT.
The study was approved by the local ethical committee
(Ethisch Comité Ghent University Hospital; amend-
ment project 2007/423 approved 19 February 2013;
B67020072805), and conducted in accordance with the
declaration of Helsinki. A signed informed consent was
obtained from every included patient.
Quality of life
QOL was assessed by means of the Medical Outcomes
Study 36-item Short Form Health Survey (SF-36v2®) and
the EuroQoL-5D (EQ-5D). The SF-36 questionnaire
contains 36 items measuring eight health domains: phys-
ical (PF) and social functioning (SF), role limitations due
to physical (RP) or emotional problems (RE), mental
health (MH), vitality (VT), bodily pain (BP), and general
perception of health (GH) [31]. Two component scores,
a physical (PCS) and a mental (MCS), are calculated
summary scores where, respectively, the physical do-
mains (PF, RP, BP, GH) or the mental domains (VT, SF,
RE, MH) will account more in the score. We assessed
SF-36 as norm-based scores to be able to compare them
directly with the general healthy population, with a
group level range of 47–53 considered as average or
normal [31]. Group scores less than 47 indicate impaired
functioning within that health domain; group scores greater
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the normative sample.
The 36th item, health transition, provides information
about perceived changes in health status. The validity
and reliability of the SF-36 has been confirmed in critic-
ally ill patients, and its use is validated in face-to-face
interviews, telephone interview, and questionnaire by
regular mail [32].
The EQ-5D is a generic QOL questionnaire that mea-
sures health in five dimensions: mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression [33].
Each dimension has three levels: no problems, moderate
problems, or severe problems. On a visual analogue scale
(VAS), patients can rate their perceived overall health
between 0 and 100. The EQ-5D is suitable for measuring
QOL in critical care [34, 35].
QOL was assessed at different time points: baseline
QOL and strictly at 3 months and 1 year after ICU dis-
charge. QOL was also assessed in August 2013, a median
of 4.1 years (3.9–4.3 years) after ICU discharge. Following
ICU admission and study inclusion, a face-to-face inter-
view to assess baseline QOL (defined as QOL 2 weeks
before ICU admission) was performed as soon as possible.
This interview was preferably taken from the patient, or
when impossible, from the proxy. Three months, 1 year,
and 4 years after ICU discharge, patients were sent the
EQ-5D and SF-36 surveys by regular mail; at 1 and 4 years,
questions concerning living situation, memories, sleep
quality, and willingness to be readmitted to an ICUFig. 1 Patient cohort. N number, AKI acute kidney injury, RRT renal replacemdepartment were added. If the questionnaires were not
returned within 1 month, patients or relatives were con-
tacted by phone to assess QOL after 1 year and after
4 years. Eventually, the family practitioner was contacted.
Statistical analysis
Data are expressed as median (interquartile range; IQR)
for continuous variables and as number (%) for categorical
variables. QOL at the different time points and charac-
teristics between both groups (AKI-RRT versus non-AKI-
RRT patients) were compared by the Mann–Whitney U
test for continuous variables and by the Chi-square test
for categorical variables. For long-term analysis of QOL,
differences between QOL at baseline (only hospital sur-
vivors), at 3 months and at 1 and 4 years after ICU dis-
charge were assessed by Chi-square (EQ-5D) or Friedman
test (SF-36). P values were two-sided and statistical signifi-
cance was set at 0.05. All statistical analyses were done
using IBM SPSS Statistics software version 21 (IBM,
Armonk, New York, USA).
Results
Characteristics of the study population
During the 1-year study period 1953 patients were in-
cluded (Fig. 1). Of these, 147 patients (7.5 %) developed
AKI with need for RRT. Of these, 121 patients (6.2 %)
received RRT. ICU (46.3 %), hospital (55.4 %), 3-month
(57.9 %), 1-year (61.1 %) and 4-year (71.1 %) mortality
rates in these patients were high. Twenty-six AKIent therapy, ICU intensive care unit
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restrictions and were excluded from further analysis.
AKI-RRT hospital survivors (44.6 %) had a 1-year and
4-year survival rate of 87.0 % and 64.8 %, respectively.
Forty-seven 1-year AKI-RRT survivors were individually
matched with 94 1-year non-AKI-RRT survivors (two
matches for all AKI-RRT patients). Of 35 4-year survivors,
three refused further cooperation, three were lost-to-
follow-up, and one had a double match. In 13 of the 28
included 4-year AKI-RRT survivors, only one good match
could be found, so matching occurred in a 1:1 ratio.
Finally, 28 4-year AKI-RRT survivors were individually
matched with 28 non-AKI-RRT patients. AKI-RRT and
non-AKI-RRT patients had similar gender, age, APACHE
II score, and admission category at 1 year and 4 years
(Table 1).
During ICU stay, 1-year and 4-year AKI-RRT patients
had higher SOFA scores compared to their respective
matches, and more needed mechanical ventilation or
vasopressors for a longer time (Table 1).Renal characteristics and renal outcomes
One-year AKI-RRT patients had higher baseline serum
creatinine concentrations and lower eGFR compared to
their matches. These measurements did not significantly
differ between 4-year AKI-RRTand non-AKI-RRT patients
(Table 1).
Respectively, 12 1-year (25.5 %) and 10 4-year AKI-
RRT patients (35.7 %) were RRT-dependent at hospital
discharge. Nine (19.1 %) of the 1-year and 8 (28.6 %) of
the 4-year AKI-RRT patients remained RRT dependent
over time.Quality of life
An overview of the persons who rated QOL, how QOL
was assessed, and the number of completed QOL surveys
is given in Table 2. Most patients rated their own QOL at
the different time points, except at baseline in 1-year
AKI-RRT patients.
Significant differences in QOL between AKI-RRT and
non-AKI-RRT survivors at each different time point
were small. Figures 2 and 3 show that the 1-year AKI-
RRT versus 1-year non-AKI-RRT patients had compar-
able baseline QOL. The 1-year AKI-RRT patients were
poorer emotionally at 3 months (RE 28.7 versus 38.4;
P = 0.035), but had a better mental score (MCS 53.3
versus 47.8; P = 0.039) and less bodily pain (BP 46.5
versus 41.6; P = 0.041) at 1 year (Fig. 3). Figures 4 and 5
show that the 4-year AKI-RRT versus 4-year non-AKI-
RRT patients were emotionally better at baseline (RE 55.9
versus 40.3; P = 0.030) (Fig. 5), but had more problems
with usual activities (81.0 % versus 47.8 %; P = 0.023), pain
(71.4 % versus 26.1 %; P = 0.003) and anxiety (61.9 %versus 17.4 %; P = 0.002) at 3 months (Fig. 4). QOL after 1
and 4 years showed no differences (Figs. 4 and 5).
Comparing QOL within each group between the dif-
ferent time points revealed that QOL particularly de-
creased after 3 months.
Evolution in QOL over time: 1-year cohort
All 1-year AKI-RRT patients reported more problems on
the EQ-5D after 3 months compared to baseline. After
1 year, they experienced fewer problems but still
more than before ICU admission. The EQ-5D showed
the same evolution for 1-year non-AKI-RRT patients
(Additional file 1A and B).
The SF-36 showed significant evolutions in QOL over
time for 1-year AKI-RRT patients in nearly all di-
mensions. QOL decreased after 3 months and improved
after 1 year, but without return to the baseline level.
QOL also remained under the level of the average popu-
lation. The same pattern, although less pronounced, was
seen in 1-year non-AKI-RRT patients (Additional file 2A
and B).
For 1-year AKI-RRT patients the median VAS scores
ranged from 70 (baseline), to 60 (3 months) and 70
(1 year) (P = 0.048). In non-AKI-RRT patients the VAS
remained the same: 68, 65 and 65 at baseline, 3 months
and 1 year after ICU discharge, respectively (P = 0.917).
Evolution in QOL over time: 4-year cohort
Changes in QOL over time assessed by the EQ-5D were
significant in AKI-RRT patients for mobility (P =
0.040), usual activities (P < 0.001), and anxiety (P = 0.040)
(Additional file 1C) and in 4-year non-AKI-RRT patients
for mobility (P = 0.017), and usual activities (P = 0.014),
with most problems at 3 months after ICU discharge
followed by an improvement in QOL after 1 year
(Additional file 1D). QOL never returned to baseline
level.
The SF-36 showed that, in both groups, QOL de-
creased after 3 months compared to baseline (Additional
file 2C and D). For the 4-year AKI-RRT patients, QOL
improved after 1 year, especially in the mental domains.
At 4 years, QOL significantly decreased physically but
improved or remained the same in the mental compo-
nents (Additional file 2C). Changes in long-term QOL in
the 4-year non-AKI-RRT patients were less pronounced
(Additional file 2D).
The 4-year AKI-RRT patients showed a decrease in
VAS after 3 months (63), and improvements after 1 (70)
and 4 years (68), but without regain of the baseline level
(70) (P = 0.044). The 4-year non-AKI-RRT patients had
the same evolution but without significance (P = 0.327).
Additional file 3 and Additional file 4 illustrate in
more detail the variability in EQ-5D and SF-36 over
time.










(N = 47) (N = 94) (N = 28) (N = 28)
Age (years) 57 (45–69) 57 (48–70) 0.897 54 (45–66) 53 (45–68) 0.718
Male gender 31 (66.0) 62 (66.0) 0.999 16 (57.1) 16 (57.1) 0.999
Body mass index (kg/m2) 26.2 (22.8-29.7) 25.9 (22.0-29.4) 0.444 27.3 (22.9-31.6) 24.5 (22.9-27.8) 0.092
Serum creatinine baseline (mg/dL)a 1.14 (0.94-1.51) 0.82 (0.66-1.04) 0.001 0.97 (0.80-1.26) 0.78 (0.65-1.11) 0.062
eGFR baseline (mL/min per 1.73 m2)a 86 (71–100) 100 (83–116) 0.007 99 (85–109) 102 (87–116) 0.629
Lives at home before admission 45 (95.7) 90 (95.75) 0.999 26 (92.9) 27 (96.4) 0.553
Activity of daily living
No limitations 25 (53.2) 47 (50.0) 0.721 18 (63.4) 21 (75.0) 0.383
Moderate limitations 19 (40.4) 42 (44.7) 0.631 7 (25.0) 7 (25.0) 0.999
Chair-bound 0 (0) 3 (3.2) 0.216 0 (0) 0 (0) NA
Bedridden 3 (6.4) 2 (2.1) 0.198 3 (10.7) 0 (0) <0.001
Hospitalization in last 6 months before ICU 20 (42.6) 46 (48.9) 0.474 10 (35.7) 14 (50.0) 0.280
Charlson comorbidity index 1 (0–3) 2 (0–3) 0.115 0 (0–2) 2 (0–3) 0.110
Type of admission
Medical 32 (68.1) 67 (71.3) 0.696 18 (64.3) 18 (64.3) 0.999
Scheduled surgery 1 (2.1) 4 (4.3) 0.519 0 (0) 4 (14.3) 0.038
Emergency surgery 10 (21.3) 18 (19.1) 0.765 7 (25.0) 3 (10.7) 0.163
Trauma 3 (6.4) 4 (4.3) 0.376 2 (7.1) 2 (7.1) 0.999
Burns 1 (2.1) 1 (1.1) 0.614 1 (3.6) 1 (3.6) 0.999
Severity of illness at ICU admission (first 24 hours)
APACHE II score 26 (21–31) 24 (20–30) 0.251 23 (20–28) 22 (18–25) 0.362
SOFA score 9 (5–11) 7 (5–10) 0.047 7 (4–12) 6 (4–9) 0.139
Mechanical ventilation 29 (61.7) 49 (52.1) 0.281 21 (75.0) 13 (46.4) 0.029
Vasopressors 21 (44.7) 37 (39.4) 0.545 11 (39.3) 9 (32.1) 0.577
RRT 11 (23.4) 0 (0) <0.001 6 (21.4) 0 (0) 0.010
Organ failure during ICU stay
Mechanical ventilation 39 (83.0) 50 (53.2) <0.001 24 (85.7) 13 (46.4) 0.002
Length of mechanical ventilation (days) 16 (3–27) 1 (0–3) <0.001 18 (4–31) 0 (0–7) <0.001
Vasopressors 36 (76.6) 42 (44.7) <0.001 21 (75.0) 10 (35.7) 0.003
Length of vasopressor therapy (days) 5 (1–8) 0 (0–3) <0.001 3 (0–10) 0 (0–3) 0.002
RRT 47 (100) 0 (0) <0.001 28 (100.0) 0 (0) <0.001
Mean SOFA score 7 (6–9) 5 (4–7) <0.001 7 (5–10) 4 (4–7) <0.001
Outcomes
ICU length of stay (days) 22 (11–42) 5 (3–9) <0.001 24 (13–49) 7 (3–10) <0.001
Readmissions 8 (17.0) 12 (12.8) 0.495 3 (10.7) 4 (14.3) 0.686
Hospital LOS, days 70 (30–100) 21 (13–44) <0.001 62 (20–130) 19 (10–46) 0.003
Do-not-resuscitate decisions 4 (8.5) 3 (3.2) 0.170 2 (7.1) 1 (3.6) 0.312
Long-term mortality 12 (25.5) 20 (21.3) 0.570 NA NA NA
Need for RRT at hospital discharge 12 (25.5) NA NA 10 (35.7) NA NA
Need for RRT at 3 months 9 (19.1) NA NA 8 (28.6) NA NA
Need for RRT at 1 year 9 (19.1) NA NA 8 (28.6) NA NA
Need for RRT at 4 years NA NA NA 8 (28.6) NA NA
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Table 1 Patient characteristics at ICU admission, organ failure during ICU admission, and outcomes (Continued)
Living situation after 1 year 46 answers 93 answers 27 answers 26 answers
Independent without additional help 25 (54.3) 47 (50.5) 0.672 16 (59.3) 14 (53.8) 0.691
Independent with some help 12 (26.1) 22 (23.7) 0.754 6 (22.2) 6 (23.1) 0.941
Together with relatives (others than spouse) 6 (13.0) 14 (15.1) 0.751 3 (11.1) 4 (15.4) 0.646
Special care facility 3 (6.5) 5 (5.4) 0.786 2 (7.4) 1 (3.8) 0.575
Other 0 (0) 5 (5.4) 0.109 0 (0) 1 (3.8) 0.304
Living situation after 4 years NA NA NA 27 answers 26 answers
Independent without additional help NA NA NA 18 (66.7) 14 (53.8) 0.340
Independent with some help NA NA NA 5 (18.5) 6 (23.1) 0.682
Together with relatives (others than spouse) NA NA NA 2 (7.4) 5 (19.2) 0.204
Special care facility NA NA NA 2 (7.4) 1 (3.8) 0.575
Other NA NA NA 0 (0) 0 (0) 0.999
Values are given as median (interquartile range) or number (%) as appropriate. a Serum creatinine at baseline was defined as serum creatinine 6 months before
ICU admission. Values were missing in 27 of the 1-year AKI-RRT patients, in 14 of the 94 1-year non-AKI-RRT patients, in 21 of the 4-year AKI-RRT patients, and in
4 of the 4-year non-AKI-RRT patients. AKI acute kidney injury, APACHE Acute Physiology and Chronic Health Evaluation, eGFR estimated glomerular filtration rate,
ICU intensive care unit, NA not applicable, RRT renal replacement therapy, SOFA Sequential Organ Failure Assessment
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level for AKI-RRT and non-AKI-RRT patients, and
under the QOL of the average population.
Additional questions after 1 year and 4 years
One and 4 years after ICU discharge, most survivors
lived independently, and only a minority stayed in a
special care facility (Table 1). There were no major
sleeping problems. One year and 4 years after ICU
discharge, AKI-RRT patients had more bad memories
than non-AKI-RRT patients (after 1 year, 17.4 % ver-
sus 4.3 %, P = 0.010; after 4 years, 21.4 % versus 3.8 %,
P = 0.055). Of the 1-year AKI-RRT patients 81.8 %Table 2 Persons who rated QOL, assessment of QOL, number of co
Baseline 3 Months
AKI-RRT non-AKI-RRT P AKI-RRT non-AKI-RRT
1-Year survivors N = 47a N = 94a N = 34b N = 71b
Patient 14 (29.8) 57 (60.6) 0.001 25 (73.5) 57 (80.3)
Partner 15 (31.9) 17 (18.1) 0.065 2 (5.9) 7 (9.9)
Son/daughter 8 (17.0) 9 (9.6) 0.200 3 (8.8) 4 (5.6)
Other family 4 (8.5) 5 (5.3) 0.465 0 (0) 0 (0)
Others 6 (12.8) 6 (6.4) 0.200 4 (11.8) 4 (11.8)
4-Year survivors N = 28a N = 27a N = 21b N = 23b
Patient 8 (28.6) 18 (66.7) 0.005 17 (81.0) 17 (73.9)
Partner 7 (25.0) 4 (14.8) 0.345 1 (4.8) 3 (13.0)
Son/daughter 6 (21.4) 2 (7.4) 0.140 2 (9.5) 1 (4.3)
Other family 3 (10.7) 3 (11.1) 0.962 0 (0) 1 (4.3)
Others 4 (14.3) 0 (0) 0.041 1 (4.8) 1 (4.3)
All values are shown as number (%). aAll QOL surveys completed by face-to-face int
completed, 32 by regular mail (69.6 %) and 14 by phone interview (30.4 %); d94 QO
(28.7 %); e27 QOL surveys completed, 18 by regular mail (66.7 %) and 9 by phone i
7 by phone interview (26.9 %); g28 QOL surveys completed, 14 by regular mail (50.0
regular mail (71.4 %) and 8 by phone interview (28.6 %). AKI acute kidney injury, QOpreferred to be readmitted to an ICU department in
case of deterioration versus 83.0 % of their 1-year
matches (P = 0.867). This number decreased to 71.4 %
for the 4-year AKI-RRT patients versus 84.6 % for the
4-year non-AKI-RRT patients (P = 0.244).
Discussion
In this prospective, single-center matched cohort study
concerning long-term outcomes and QOL of AKI-RRT
patients, we found high mortality rates and lower QOL
levels compared to the general population.
Similar to others, we found high hospital mortality
(55 %) in this cohort of critically ill AKI-RRT patients,mpleted QOL surveys
1 Year 4 Years
P AKI-RRT non-AKI-RRT P AKI-RRT Non-AKI-RRT P
N = 46c N = 94d
0.434 33 (71.7) 65 (69.1) 0.753
0.496 7 (15.2) 13 (13.8) 0.826
0.540 1 (2.2) 8 (8.5) 0.151
0.999 1 (2.2) 2 (2.1) 0.986
0.268 4 (8.7) 6 (6.4) 0.618
N = 27e N = 26f N = 28g N = 28h
0.578 22 (81.5) 22 (84.6) 0.761 24 (85.7) 21 (77.8) 0.313
0.340 3 (11.1) 3 (11.5) 0.961 1 (3.6) 2 (7.4) 0.553
0.496 1 (3.7) 0 (0) 0.322 0 (0) 2 (7.4) 0.150
0.334 0 (0) 0 (0) 0.999 0 (0) 2 (7.4) 0.150
0.947 1 (3.7) 1 (3.4) 0.978 3 (10.7) 1 (3.7) 0.299
erviews; ball QOL surveys completed by regular mail; c46 QOL surveys
L surveys completed, 67 by regular mail (71.3 %) and 27 by phone interview
nterview (33.3 %); f26 QOL surveys completed, 19 by regular mail (73.1 %) and
%) and 14 by phone interview (50.0 %); h28 QOL surveys completed, 20 by
L quality of life, RRT renal replacement therapy
Fig. 2 EQ-5D assessments in the 1-year cohort. Percentages of patients with some or severe problems per dimension at the three different time
points. The X-axis represents the different dimensions of the EQ-5D. The Y-axis represents the percentages (%) of patients with some or severe
problems in a respective dimension. Only significant P values (Chi-Square test) are shown above the respective dimensions. AKI acute kidney
injury, QOL quality of life, RRT renal replacement therapy
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follow-up (58 % at 3 months, 61 % at 1 year, 71 % at
4 years) [4, 14, 15, 20, 36].
At hospital discharge and at long term, a quarter of
AKI-RRT hospital survivors were RRT-dependent. These
findings are similar to those reported in the literature [37].Fig. 3 SF-36 assessments in the 1-year cohort. Norm-based median scores
the different domains of the SF-36. The Y-axis represents the norm-based m
median score between 47 and 53 in a group of patients is considered as n
impaired functioning or below average; norm-based median scores above
P values (Mann–Whitney U analysis) are shown above the respective doma
mental component score, MH mental health, PCS physical component scor
RP role physical, RRT renal replacement therapy, SF social functioning, VT viLong-term survival data would be meaningless without
considering QOL. Remarkably, there was no difference
in QOL at different time points between AKI-RRT
patients and matched non-AKI-RRT patients, although
changes in QOL over time were less pronounced in
the latter group. QOL decreased 3 months after ICUper domain at the three different time points. The X-axis represents
edian scores in a respective domain of the SF-36. A norm-based
ormal or average. Norm-based median scores below 47 indicate
53 indicate better functioning or above average. Only significant
ins. AKI acute kidney injury, BP bodily pain, GH general health, MCS
e, PF physical functioning, QOL quality of life, RE role emotional,
tality
Fig. 4 EQ-5D assessments in the 4-year cohort. Percentages of patients with some or severe problems per dimension at the four different time
points. The X-axis represents the different dimensions of the EQ-5D. The Y-axis represents the percentages (%) of patients with some or severe
problems in a respective dimension. Only significant P values (Chi Square test) are shown above the respective dimensions. AKI acute kidney
injury, QOL quality of life, RRT renal replacement therapy
Oeyen et al. Critical Care  (2015) 19:289 Page 8 of 11discharge compared to baseline, improved after 1 year,
and stayed the same or improved slightly after 4 years,
but still remained under baseline level.
The fact that long-term QOL had the same evolution
over time in AKI-RRT and non-AKI-RRT patients was
quite surprising suggesting that the AKI-RRT compo-
nent during critical illness did not have an important
impact on long-term QOL. Others reported very similar
findings; however, these studies reported only on QOL
after 6 months, and in one study not all AKI patients
received RRT, and some patients received RRT without
AKI [20, 21].
The fact that AKI-RRT patients were more severely ill
during their ICU stay compared to matched patients had
no influence on QOL over the years. This is in accord-
ance with the findings of Orwelius et al. [38]. In a multi-
center study they found that, 6 months after ICU
discharge, perceived QOL in sepsis patients did not
differ from ICU survivors with other diagnoses, even
though these sepsis patients were more severely ill, and
had a longer ICU stay. Another study by Orwelius
suggested that long-term QOL was mainly affected by
co-morbidity [39]. In our study AKI-RRT and non-AKI-
RRT patients had a very comparable co-morbidity and
medical history, which may explain the comparable
long-term QOL between groups in our study.QOL was perceived as acceptable and both AKI-RRT
and non-AKI-RRT patients reported low dependence in
daily life later on. The number of AKI-RRT and non-
AKI-RRT patients who agreed to undergo life-sustaining
interventions again in case of deterioration remained
high. However, QOL was lower compared to that of the
average population in both groups specifically in the
more physical domains. This is in accordance with the
findings of others [12–16, 20, 21].
Our study has several strengths. First, the matched
cohort design demonstrates the real impact of AKI-RRT
upon long-term QOL. This has not been evaluated thus far.
Second, QOL was assessed with validated questionnaires at
baseline, which allows for the only reliable evaluation of
QOL over time without recall or selection bias [11, 40].
Third, the additional questions and VAS score allowed
evaluation of the patients’ perception of the ICU admission
and the consequences of severe illness. Finally, most studies
report QOL in AKI survivors as a short-term endpoint,
while this study also provides data for a longer follow-up
period. Strict time intervals of 3 months and 1 year after
ICU discharge were respected in all patients. For long-term
assessment of QOL, an arbitrary time point was chosen
(August 2013) which was between 47 and 52 months after
ICU discharge for all patients. Response rate was very high
and only three patients were lost to follow-up.
Fig. 5 SF-36 assessments in the 4-year cohort. Norm-based median scores per domain at the four different time points. The X-axis represents the
different domains of the SF-36. The Y-axis represents the norm-based median scores in a respective domain of the SF-36. A norm-based median
score between 47 and 53 in a group of patients is considered as normal or average. Norm-based median scores below 47 indicate impaired
functioning or below average; norm-based median scores above 53 indicate better functioning or above average. Only significant P values
(Mann–Whitney U analysis) are shown above the respective domains. AKI acute kidney injury, BP bodily pain, GH general health, MCS mental
component score, MH mental health, PCS physical component score, PF physical functioning, QOL quality of life, RE role emotional, RP role
physical, RRT renal replacement therapy, SF social functioning, VT vitality
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single-center data from a university hospital may not
reflect general practice and may limit external validity of
the data. Second, although 1-year and 4-year AKI-RRT
patients were matched to non-AKI-RRT patients based
on four criteria, we cannot exclude that matched
patients had a different profile compared to AKI-RRT
patients. Third, the study cohort is relatively small and
may lack statistical power to detect differences among
the QOL domains in our study patients. Fourth, medical
decisions leading to ICU referral may have selected for
patients with better prospects. Fifth, long-term QOL
may also be modified by events happening to the patient
after hospital discharge. These were not recorded in the
present study.
Conclusions
We found high mortality rates in AKI-RRT patients.
However, in long-term critically ill AKI-RRT survi-
vors, QOL was comparable to matched long-term
critically ill survivors without AKI-RRT, but lower
than in the general population. The majority of AKI-RRT patients wanted to be readmitted to the ICU
when needed, despite a higher severity of illness
compared to matched non-AKI-RRT patients, and
despite the fact that one quarter had persistent dialy-
sis dependency.
Key messages
 Long-term critically ill AKI-RRT survivors
have comparable QOL to matched
long-term critically ill survivors
without RRT.
 QOL in long-term AKI-RRT survivors is
lower than in the general population.
 AKI-RRT patients are more severely ill
during their ICU stay compared to matched
non-AKI-RRT patients.
 The majority of long-term AKI-RRT survivors
prefer to be readmitted to the ICU department
in case of deterioration.
 One quarter of long-term AKI-RRT survivors
have persistent dialysis dependency.
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Additional file 1: EQ-5D assessments over time. In this additional file,
evolutions in EQ-5D assessments are described through figures in the
1-year cohort (47 AKI-RRT (A) and 94 non-AKI-RRT patients (B)) and in the
4-year cohort (28 AKI-RRT (C) patients and 28 non-AKI-RRT patients (D)).
Percentages of patients with some or severe problems in the different
dimensions of the EQ-5D are given over the different time points:
baseline, 3 months and 1 year (1-year cohort) and baseline, 3 months,
1 year and 4 years (4-year cohort). (PDF 111 kb)
Additional file 2: SF-36 assessments over time. In this additional file,
evolutions in SF-36 assessments are described through figures in the
1-year cohort (47 AKI-RRT (A) and 94 non-AKI-RRT patients (B)) and in the
4-year cohort (28 AKI-RRT (C) patients and 28 non-AKI-RRT patients (D)).
Percentages of patients with some or severe problems in the different
domains of the SF-36 are given over the different time points: baseline,
3 months and 1 year (1-year cohort) and baseline, 3 months, 1 year and
4 years (4-year cohort). (PDF 126 kb)
Additional file 3: Variability in EQ-5D. In this additional file, more
detailed information is given regarding variability of the EQ-5D at the
different time points in the 1-year cohort and 4-year cohort. Percentages
and 95 % confidence intervals of patients with some or severe problems
on the respective dimensions of the EQ-5D over time are given in a table.
(PDF 60 kb)
Additional file 4: Variability in SF-36. In this additional file, more
detailed information is given regarding variability of the SF-36 at the
different time points in the 1-year cohort and 4-year cohort. Median
norm-based scores with interquartile ranges on the different domains
of the SF-36 over time are given in a table. (PDF 81 kb)Abbreviations
AKI: Acute kidney injury; APACHE: Acute Physiology and Chronic Health
Evaluation; BP: Bodily pain; eGFR: Estimated glomerular filtration rate;
EQ-5D: EuroQoL-5D; GH: General health; ICU: Intensive care unit;
IQR: Interquartile range; LOS: Length of stay; MCS: Mental component score;
MH: Mental health; MICU: Medical intensive care unit; PCS: Physical
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Assessment; VAS: Visual analogue scale; VT: Vitality.
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